AGI-25696
Catalog No. A20250
AGI-25696 is a methionine adenosyltransferase 2A (MATA2 ) inhibitors useful for treatment of cancer. AGI-25696 blocks growth of MTAP-deleted tumors in vivo.
- Jennifer Kim, .et al. Intratarget Microdosing for Deep Phenotyping of Multiple Drug Effects in the Live Brain, Front Bioeng Biotechnol, 2022, Mar 18;10:855755 PMID: 35372313
Catalog Num | A20250 |
---|---|
M. Wt | 414.46 |
Formula | C27H18N4O |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 2201066-35-3 |
Synonyms | AGI25696, AGI 25696 |
SMILES | O=C1C(C2=CC=C3N=CC=CC3=C2)=CNC4=C(C5=CC=CC=C5)C(C6=CC=CC=C6)=NN14 |
AGI-25696 is a methionine adenosyltransferase 2A (MATA2 ) inhibitors useful for treatment of cancer. AGI-25696 blocks growth of MTAP-deleted tumors in vivo.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.13 mL | 120.64 mL | 241.28 mL |
0.5 mM | 4.83 mL | 24.13 mL | 48.26 mL |
1 mM | 2.41 mL | 12.06 mL | 24.13 mL |
5 mM | 0.48 mL | 2.41 mL | 4.83 mL |
*The above data is based on the productmolecular weight 414.46. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.